Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients Article

Lee, Eudocia Q, Weller, Michael, Sul, Joohee et al. (2020). Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients . NEURO-ONCOLOGY, 22(5), 601-612. 10.1093/neuonc/noaa015

Open Access International Collaboration

cited authors

  • Lee, Eudocia Q; Weller, Michael; Sul, Joohee; Bagley, Stephen J; Sahebjam, Solmaz; van den Bent, Martin; Ahluwalia, Manmeet; Campian, Jian L; Galanis, Evanthia; Gilbert, Mark R; Holdhoff, Matthias; Lesser, Glenn J; Lieberman, Frank S; Mehta, Minesh P; Penas-Prado, Marta; Schreck, Karisa C; Strowd, Roy E; Vogelbaum, Michael A; Walbert, Tobias; Chang, Susan M; Nabors, L Burt; Grossman, Stuart; Reardon, David A; Wen, Patrick Y

sustainable development goals

authors

publication date

  • May 1, 2020

webpage

published in

keywords

  • ADJUVANT TEMOZOLOMIDE
  • CANCER
  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • RADIATION
  • RADIOTHERAPY
  • RANDOMIZED PHASE-III
  • RECURRENT GLIOBLASTOMA
  • SAFETY
  • SURVIVAL
  • Science & Technology
  • TIME
  • TREATING FIELDS
  • clinical trials
  • eligibility
  • exclusion criteria
  • inclusion criteria
  • primary brain tumor

Digital Object Identifier (DOI)

publisher

  • OXFORD UNIV PRESS INC

start page

  • 601

end page

  • 612

volume

  • 22

issue

  • 5